Low blood glucose is linked to worsening eye disease in a new study. Medscape Medical News
Author: Medscape
TRS 2025
Read clinically focused news coverage of key developments from TRS 2025 Medscape Ophthalmology
Atropine Drops Not Tied to Ocular Issues in Kids With Myopia
Children with myopia experience more eye problems than those without the condition, but atropine eye drops do not appear to increase that risk, a new study finds. Medscape Medical News
Tips for Being Efficient on Night Shift
Dr Kaitlin Sanzone discusses tips and tricks to be efficient on night shift. Medscape
Poll: Are You Practicing Medicine Abroad? Would You Like To?
Medscape’s editors are investigating what is needed to practice medicine in various countries around the world, and we want to hear from you! Medscape Reader Polls
AMD Gene Therapy Sustains Efficacy in First Two-Eye Study
A gene therapy for neovascular age-related macular degeneration in the second eye shows safety and preservation of vision and anatomy a year after the first eye was treated. Medscape Medical News
Do You Really See What I See?
Do we all see the same color when we look at a banana? Dr F. Perry Wilson comments on a study that explores the human perception of color. Medscape
Cancer Patients Request Financial Support Exceeding $5000
Researchers analyzed requests for assistance from patients with cancer enrolled in a novel digital support registry. Medscape Medical News
Light Therapy Can Prevent Dry Eye After Cataract Surgery
Low-level light therapy administered before and after cataract surgery is a safe and effective approach for preventing dry eye disease in patients undergoing the procedure, a clinical trial shows. Medscape Medical News
Does Blockage in Retinal Artery Signal Heart Issues?
Retinal artery occlusion is more than just an ocular event — it also serves as an independent marker of an increased risk for subsequent cardiovascular events, a new meta-analysis shows. Medscape Medical News
US FDA Declines to Approve Outlook Therapeutics’ Eye Disease Drug, Shares Plummet
Outlook Therapeutics said on Thursday the U.S. health regulator has again declined to approve its experimental eye drug, citing a lack of substantial evidence of… Reuters Health Information
Advances in Neovascular Macular Degeneration From ASRS 2025
Advances in neovascular macular degeneration, presented at ASRS 2025, include efficacy of aflibercept 8 mg as well as emerging gene therapies, as reported by Dr Sunir Garg. Medscape
AI-Powered Model Can Classify Types of Optic Nerve Damage
A deep-learning analysis of three-dimensional optical coherence tomography scans shows promising accuracy in distinguishing among glaucoma, optic neuropathy, optic neuritis, and healthy eyes, according to a recent study. Medscape Medical News
Diabetic Macular Edema: Second-Gen Anti-VEGFs Lead the Way
Medscape Medical News
Vitamin D Deficiency Tied to Cataract Risk in Young Adults
Low serum levels of vitamin D are associated with an increased risk for development of cataracts, particularly among young people, new research shows. Medscape Medical News
Pill That Slows Aging? Meds May Boost Health Span
Metformin, rapamycin, and senolytics show multifaceted effects on aging biology that could transform how clinicians approach chronic disease prevention. Medscape Medical News
AMD Light Therapy Restores Vision Gains Post-Treatment Pause
A tabletop light therapy device led to vision improvements over 4.5 years and a long pause between treatments in people with dry age-related macular degeneration. Medscape Medical News
Long-Term Use of Metformin May Prevent AMD in Diabetes
Patients with diabetes who use metformin for at least 5 consecutive years are less likely to develop AMD, particularly the dry type, a recent study shows. Medscape Medical News
FDA Approves New ADC for Lung Cancer Treatment
Dr Mark Kris discusses datopotamab deruxtecan as a potent option post-osimertinib but warns of toxicity patterns unfamiliar to many lung oncologists. Medscape Oncology
Simple, Noninvasive Eye Tracking May Flag Cognitive Decline
Naturalistic gaze patterns appear to be a simple, noninvasive, and reliable indicator of cognitive decline, new research suggests. Medscape Medical News